STOCK TITAN
  1. Home
  2. Sec-filings
  3. GALT
  4. [ARS] GALECTIN THERAPEUTICS INC SEC Filing

[ARS] GALECTIN THERAPEUTICS INC SEC Filing

Filing Impact
(No impact)
Filing Sentiment
(Neutral)
Form Type
ARS
ARS - GALECTIN THERAPEUTICS INC

ARS Filing - GALECTIN THERAPEUTICS INC

This filing is available as a PDF document.

Filing Type: ARS

Company: GALECTIN THERAPEUTICS INC (GALT)

Acceptance Date: 2025-10-22T08:01:40.000Z

View PDF Document

Source: View Original Filing on SEC EDGAR

Stock GALT logo
Galectin Therapeutics Inc

NASDAQ:GALT

GALT Rankings

#3780 Ranked by Market Cap
N/A Ranked by Dividends

GALT Latest News

Oct 20, 2025
Galectin Therapeutics to Present at the H.C. Wainwright 9th Annual MASH Investor Conference
Oct 7, 2025
Galectin Therapeutics to Present at the American Association for the Study of Liver Disease (AASLD) Liver Meeting 2025
Sep 2, 2025
Galectin Therapeutics to Present at the H.C. Wainwright 27th Annual Global Investment Conference
Aug 14, 2025
Galectin Therapeutics Reports Financial Results for the Quarter Ended June 30, 2025 and Provides Business Update
Jul 9, 2025
Galectin Therapeutics Announces New $10 Million Credit Line from Richard E. Uihlein, Sufficient to Cover Expected Expenditures Through June 2026

GALT Latest SEC Filings

Oct 22, 2025
[DEF 14A] GALECTIN THERAPEUTICS INC Definitive Proxy Statement
Oct 10, 2025
[Form 5] GALECTIN THERAPEUTICS INC Annual Statement of Beneficial Ownership
Sep 15, 2025
[Form 4] GALECTIN THERAPEUTICS INC Insider Trading Activity
Sep 15, 2025
[Form 4] GALECTIN THERAPEUTICS INC Insider Trading Activity
Sep 8, 2025
[8-K] Galectin Therapeutics Inc. Reports Material Event

GALT Stock Data

339.52M
44.47M
30.08%
16.46%
12.47%
Biotechnology
Pharmaceutical Preparations
Link
United States
NORCROSS